Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Vorbach

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Radiation Oncology (London, England)|July 17, 2025
Stereotactic body radiotherapy for single and multiple early-stage non-small cell lung cancer in patients aged ≥ 80 yearsSamuel M Vorbach, Thomas Seppi, Jan C Peeken, et al.
Journal of Ovarian Research|June 26, 2026
Making themselves scarce: immune cells in the ovaryBettina Toth, Elisabeth Reiser, Samuel M Vorbach, et al.
Journal of Medical Internet Research|April 25, 2025
Sustainability and Time Trends in Electronic Patient-Reported Outcome Assessment in Routine Cancer Care: Systematic Scoping Review and Follow-Up SurveyNiclas J Hubel, Samuel M Vorbach, Kelly M de Ligt, et al.
Head & Neck|August 8, 2024
A novel prognostic score (HAMP) for head and neck cancer patients with single and multiple SBRT-treated lung metastases derived from retrospective analyses of survival outcomeSamuel M Vorbach, Thomas Seppi, Manuel P Sarcletti, et al.
Critical Reviews in Oncology/Hematology|December 25, 2025
What's missing in patient-reported outcome reporting? A scoping review and aggregated trial-level analysis of completion rates in oncology randomized controlled trialsDaniela Krepper, Niclas J Hubel, Samuel M Vorbach, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 1, 2026
Assessing the assessment: a scoping review of the mode of patient-reported outcome assessment in solid cancer clinical trialsNiclas Hubel, Daniela Krepper, Lotte van der Weijst, et al.
Current Oncology (Toronto, Ont.)|May 26, 2026
Quality of Life and Healthcare Experiences of Patients with Anal Cancer: A Mixed-Methods StudyAndreia F Moura, Catarina S Padilla, Samuel M Vorbach, et al.
NPJ Precision Oncology|April 22, 2025
Multidimensional differences of right- and left-sided colorectal cancer and their impact on targeted therapiesMarwa Abdel Hamid, Lorenz M Pammer, Silvia Oberparleiter, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 12, 2025
Short-course radiotherapy versus long-course chemoradiotherapy in total neoadjuvant therapy of rectal cancer - A multicenter analysis of early outcomes and toxicityGeorg Wurschi, Miriam Kesselmeier, Melanie Schneider, et al.
International Journal of Cancer|February 18, 2026
Oxaliplatin-induced neuropathy after total neoadjuvant therapy for rectal cancer: Dose-response relationship and impact on quality of lifeGeorg W Wurschi, Andreas Hinz, Melanie Schneider, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Radiation Oncology (London, England)|July 17, 2025
Stereotactic body radiotherapy for single and multiple early-stage non-small cell lung cancer in patients aged ≥ 80 yearsSamuel M Vorbach, Thomas Seppi, Jan C Peeken, et al.
Journal of Ovarian Research|June 26, 2026
Making themselves scarce: immune cells in the ovaryBettina Toth, Elisabeth Reiser, Samuel M Vorbach, et al.
Journal of Medical Internet Research|April 25, 2025
Sustainability and Time Trends in Electronic Patient-Reported Outcome Assessment in Routine Cancer Care: Systematic Scoping Review and Follow-Up SurveyNiclas J Hubel, Samuel M Vorbach, Kelly M de Ligt, et al.
Head & Neck|August 8, 2024
A novel prognostic score (HAMP) for head and neck cancer patients with single and multiple SBRT-treated lung metastases derived from retrospective analyses of survival outcomeSamuel M Vorbach, Thomas Seppi, Manuel P Sarcletti, et al.
Critical Reviews in Oncology/Hematology|December 25, 2025
What's missing in patient-reported outcome reporting? A scoping review and aggregated trial-level analysis of completion rates in oncology randomized controlled trialsDaniela Krepper, Niclas J Hubel, Samuel M Vorbach, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 1, 2026
Assessing the assessment: a scoping review of the mode of patient-reported outcome assessment in solid cancer clinical trialsNiclas Hubel, Daniela Krepper, Lotte van der Weijst, et al.
Current Oncology (Toronto, Ont.)|May 26, 2026
Quality of Life and Healthcare Experiences of Patients with Anal Cancer: A Mixed-Methods StudyAndreia F Moura, Catarina S Padilla, Samuel M Vorbach, et al.
NPJ Precision Oncology|April 22, 2025
Multidimensional differences of right- and left-sided colorectal cancer and their impact on targeted therapiesMarwa Abdel Hamid, Lorenz M Pammer, Silvia Oberparleiter, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 12, 2025
Short-course radiotherapy versus long-course chemoradiotherapy in total neoadjuvant therapy of rectal cancer - A multicenter analysis of early outcomes and toxicityGeorg Wurschi, Miriam Kesselmeier, Melanie Schneider, et al.
International Journal of Cancer|February 18, 2026
Oxaliplatin-induced neuropathy after total neoadjuvant therapy for rectal cancer: Dose-response relationship and impact on quality of lifeGeorg W Wurschi, Andreas Hinz, Melanie Schneider, et al.
Pageof 3